Title |
Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit
|
---|---|
Published in |
Critical Care, April 2014
|
DOI | 10.1186/cc13844 |
Pubmed ID | |
Authors |
François Lauzier, John Muscedere, Éric Deland, Demetrios Jim Kutsogiannis, Michael Jacka, Diane Heels-Ansdell, Mark Crowther, Rodrigo Cartin-Ceba, Michael J Cox, Nicole Zytaruk, Denise Foster, Tasnim Sinuff, France Clarke, Patrica Thompson, Steven Hanna, Deborah Cook, the Co-operative Network of Critical Care Knowledge Translation for Thromboprophylaxis (CONECCKT-T) Investigators and the Canadian Critical Care Trials Group |
Abstract |
Heparin is safe and prevents venous thromboembolism in critical illness. We aimed to determine the guideline concordance for thromboprophylaxis in critically ill patients and its predictors, and to analyze factors associated with the use of low molecular weight heparin (LMWH), as it may be associated with a lower risk of pulmonary embolism and heparin-induced thrombocytopenia without increasing the bleeding risk. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 13% |
Canada | 1 | 13% |
Greece | 1 | 13% |
Unknown | 5 | 63% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 50% |
Science communicators (journalists, bloggers, editors) | 2 | 25% |
Scientists | 1 | 13% |
Practitioners (doctors, other healthcare professionals) | 1 | 13% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Denmark | 1 | 1% |
Egypt | 1 | 1% |
Brazil | 1 | 1% |
Unknown | 77 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 14 | 18% |
Researcher | 11 | 14% |
Student > Postgraduate | 9 | 11% |
Student > Ph. D. Student | 7 | 9% |
Student > Bachelor | 6 | 8% |
Other | 25 | 31% |
Unknown | 8 | 10% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 54 | 68% |
Nursing and Health Professions | 3 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
Agricultural and Biological Sciences | 2 | 3% |
Biochemistry, Genetics and Molecular Biology | 2 | 3% |
Other | 3 | 4% |
Unknown | 14 | 18% |